North America Large Molecule Bioanalytical Testing Services Market Size, 2028

North America Large Molecule Bioanalytical Testing Services Market Size, Share & Industry Trends Analysis Report By End-user (SMEs and Large Firms), By Test Type, By Type (ADA, Pharmacokinetics), By Phase, By Therapeutic Areas, By Country and Growth Forecast, 2022 - 2028

Published Date: October-2022 | Number of Pages: 103 | Format: PDF | Report ID: KBV-20914

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Large Molecule Bioanalytical Testing Services Market, by End-user
1.4.2 North America Large Molecule Bioanalytical Testing Services Market, by Test Type
1.4.3 North America Large Molecule Bioanalytical Testing Services Market, by Type
1.4.4 North America Large Molecule Bioanalytical Testing Services Market, by Phase
1.4.5 North America Large Molecule Bioanalytical Testing Services Market, by Therapeutic Areas
1.4.6 North America Large Molecule Bioanalytical Testing Services Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Large Molecule Bioanalytical Testing Services Market

Chapter 4. North America Large Molecule Bioanalytical Testing Services Market by End-user
4.1 North America SMEs Market by Country
4.2 North America Large Firms Market by Country

Chapter 5. North America Large Molecule Bioanalytical Testing Services Market by Test Type
5.1 North America Bioavailability Market by Country
5.2 North America ADME Market by Country
5.3 North America PD Market by Country
5.4 North America Bioequivalence Market by Country
5.5 North America Others Market by Country

Chapter 6. North America Large Molecule Bioanalytical Testing Services Market by Type
6.1 North America ADA Market by Country
6.2 North America Pharmacokinetics Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Large Molecule Bioanalytical Testing Services Market by Phase
7.1 North America Clinical Market by Country
7.2 North America Pre-clinical Market by Country
7.3 North America Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
7.3.1 North America With Antibody Market by Country
7.3.2 North America Without Antibody (ELISA Based Assay) Market by Country

Chapter 8. North America Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
8.1 North America Oncology Market by Country
8.2 North America Neurology Market by Country
8.3 North America Infectious Diseases Market by Country
8.4 North America Cardiology Market by Country
8.5 North America Others Market by Country

Chapter 9. North America Large Molecule Bioanalytical Testing Services Market by Country
9.1 US Large Molecule Bioanalytical Testing Services Market
9.1.1 US Large Molecule Bioanalytical Testing Services Market by End-user
9.1.2 US Large Molecule Bioanalytical Testing Services Market by Test Type
9.1.3 US Large Molecule Bioanalytical Testing Services Market by Type
9.1.4 US Large Molecule Bioanalytical Testing Services Market by Phase
9.1.4.1 US Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.1.5 US Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.2 Canada Large Molecule Bioanalytical Testing Services Market
9.2.1 Canada Large Molecule Bioanalytical Testing Services Market by End-user
9.2.2 Canada Large Molecule Bioanalytical Testing Services Market by Test Type
9.2.3 Canada Large Molecule Bioanalytical Testing Services Market by Type
9.2.4 Canada Large Molecule Bioanalytical Testing Services Market by Phase
9.2.4.1 Canada Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.2.5 Canada Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.3 Mexico Large Molecule Bioanalytical Testing Services Market
9.3.1 Mexico Large Molecule Bioanalytical Testing Services Market by End-user
9.3.2 Mexico Large Molecule Bioanalytical Testing Services Market by Test Type
9.3.3 Mexico Large Molecule Bioanalytical Testing Services Market by Type
9.3.4 Mexico Large Molecule Bioanalytical Testing Services Market by Phase
9.3.4.1 Mexico Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.3.5 Mexico Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.4 Rest of North America Large Molecule Bioanalytical Testing Services Market
9.4.1 Rest of North America Large Molecule Bioanalytical Testing Services Market by End-user
9.4.2 Rest of North America Large Molecule Bioanalytical Testing Services Market by Test Type
9.4.3 Rest of North America Large Molecule Bioanalytical Testing Services Market by Type
9.4.4 Rest of North America Large Molecule Bioanalytical Testing Services Market by Phase
9.4.4.1 Rest of North America Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.4.5 Rest of North America Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas

Chapter 10. Company Profiles
10.1 IQVIA Holdings, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Recent strategies and developments:
10.1.4.1 Product Launches and Product Expansions:
10.1.4.2 Geographical Expansions:
10.2 SGS S.A.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Geographical Expansions:
10.3 Intertek Group PLC
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.4 ICON plc
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Recent strategies and developments:
10.4.4.1 Acquisition and Mergers:
10.5 Charles River Laboratories International, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Recent strategies and developments:
10.5.4.1 Acquisition and Mergers:
10.6 Thermo Fisher Scientific, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.7 Syneos Health, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.8 Laboratory Corporation Of America Holdings
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Recent strategies and developments:
10.8.4.1 Geographical Expansions:
10.9 Pace Analytical Services, LLC
10.9.1 Company Overview

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities